By Katryna Perera ( February 6, 2024, 7:40 PM EST) -- A New York federal judge trimmed a proposed class action against COVID-19 test-maker Co-Diagnostics and its executives, but said investors sufficiently alleged some statements made during the class period misrepresented that sales and demand for the tests were on the decline, and the defendants knew as such....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.